Electroconvulsive Therapy in Super Refractory Status Epilepticus: Case Series with a Defined Protocol

Super-refractory status epilepticus (SRSE) represents a neurological emergency that is characterized by a lack of response to the third line of antiepileptic treatment, including intravenous general anesthetics. It is a medical challenge with high morbidity and mortality. Electroconvulsive therapy (...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: García López, Beatriz, Gómez Menendez, Ana Isabel, Vázquez Sánchez, Fernando, Pérez Cabo, Eva, Isidro Mesas, Francisco, Zabalegui Pérez, Arturo, Muñóz Siscart, Ignacio, Lloria Gil, María Carmen, Soto Cámara, Raúl, González Bernal, Jerónimo J., González Sánchez, Josefa, Aguilar Parra, José Manuel, Trigueros Ramos, Rubén, López Liria, Remedios, Wesenberg Kjær, Troels
Aineistotyyppi: info:eu-repo/semantics/article
Kieli:English
Julkaistu: MDPI 2020
Aiheet:
Linkit:http://hdl.handle.net/10835/8298
Kuvaus
Yhteenveto:Super-refractory status epilepticus (SRSE) represents a neurological emergency that is characterized by a lack of response to the third line of antiepileptic treatment, including intravenous general anesthetics. It is a medical challenge with high morbidity and mortality. Electroconvulsive therapy (ECT) has been recommended as a nonpharmacologic option of treatment after other alternatives are unsuccessful. Its effect on the cessation of SRSE has been minimally investigated. The objective of this article is to analyze the effect of ECT on SRSE. For this purpose, a multidisciplinary team created a protocol based on clinical guidelines similar to those described previously by Ray et al. (2017). ECT was applied to six patients with SRSE after the failure of antiepileptic treatment and pharmacologic coma.The objective of each ECT session was to elicit a motor seizure for at least 20 s. SRSE was resolved in all patients after several days of treatment, including ECT as a therapy, without relevant adverse effects. Thus, ECT is an effective and feasible option in the treatment of SRSE, and its place in the algorithm in treatment should be studied due to the uncommon adverse effects and the noninvasive character of the therapy.